Butterfly Network BFLY
NYSE BFLY
$9.16 -0.01 (-0.11%)
As of: Aug 20, 2026 · 3:59 PM EDT

Butterfly Network (BFLY) Non-Current Deffered Revenue (2020 - 2026)

Butterfly Network (BFLY) posted Non-Current Deffered Revenue of $10.2 million for Q2 2026, up 5.75% sequentially from $9.6 million in Q1 2026, and up 40.85% YoY from $7.2 million in Q2 2025.

Butterfly Network (BFLY) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends

Butterfly Network has reported Non-Current Deffered Revenue for 7 years, with the latest figure at $10.2 million in Q2 2026.

  • Quarterly Non-Current Deffered Revenue rose 40.85% year-over-year to $10.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.2 million (up 40.85% YoY) and the FY2025 annual result came in at $9.4 million, up 28.38% from the prior year.
  • Non-Current Deffered Revenue climbed to $10.2 million in Q2 2026 per BFLY's latest filing, from $9.6 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $10.2 million in Q2 2026 and troughed at $4.3 million in Q1 2023.
  • A 5-year average of $7.1 million and a median of $7.2 million in 2024 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue tumbled 30.74% in 2023, then soared 66.14% in 2024.
  • Over 5 years, Non-Current Deffered Revenue stood at $5.0 million in 2022, then soared by 49.16% to $7.4 million in 2023, then fell by 1.07% to $7.3 million in 2024, then grew by 28.38% to $9.4 million in 2025, then advanced by 8.45% to $10.2 million in 2026.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $10.2 million, $9.6 million, and $9.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 539.34 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -
10 Butterfly Network 2.41 Bn 2.28 Bn 23.29 Mn 10.19 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 10.19 Mn
Mar 31, 2026 9.63 Mn
Dec 31, 2025 9.39 Mn
Sep 30, 2025 7.91 Mn
Jun 30, 2025 7.23 Mn
Mar 31, 2025 7.60 Mn
Dec 31, 2024 7.32 Mn
Sep 30, 2024 7.04 Mn
Jun 30, 2024 7.36 Mn
Mar 31, 2024 7.22 Mn
Dec 31, 2023 7.39 Mn
Sep 30, 2023 5.27 Mn
Jun 30, 2023 6.03 Mn
Mar 31, 2023 4.34 Mn
Dec 31, 2022 4.96 Mn
Sep 30, 2022 5.59 Mn
Jun 30, 2022 6.95 Mn
Mar 31, 2022 6.27 Mn
Dec 31, 2021 5.48 Mn
Sep 30, 2021 4.88 Mn